443 related articles for article (PubMed ID: 17448564)
61. A cis-acting regulatory variant in the IL2RA locus.
Qu HQ; Verlaan DJ; Ge B; Lu Y; Lam KC; Grabs R; Harmsen E; Hudson TJ; Hakonarson H; Pastinen T; Polychronakos C
J Immunol; 2009 Oct; 183(8):5158-62. PubMed ID: 19794070
[TBL] [Abstract][Full Text] [Related]
62. HLA transgenic mice as models of human autoimmune diseases.
Das P; Abraham R; David C
Rev Immunogenet; 2000; 2(1):105-14. PubMed ID: 11324683
[TBL] [Abstract][Full Text] [Related]
63. Association of MYO9B haplotype with type 1 diabetes.
Santiago JL; Martínez A; Núñez C; de la Calle H; Fernández-Arquero M; de la Concha EG; Urcelay E
Hum Immunol; 2008 Feb; 69(2):112-5. PubMed ID: 18361936
[TBL] [Abstract][Full Text] [Related]
64. Genetic developments in autoimmune thyroid disease: an evolutionary process.
Zeitlin AA; Simmonds MJ; Gough SC
Clin Endocrinol (Oxf); 2008 May; 68(5):671-82. PubMed ID: 18081880
[TBL] [Abstract][Full Text] [Related]
65. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits.
Chelala C; Duchatelet S; Joffret ML; Bergholdt R; Dubois-Laforgue D; Ghandil P; Pociot F; Caillat-Zucman S; Timsit J; Julier C
Diabetes; 2007 Feb; 56(2):522-6. PubMed ID: 17259401
[TBL] [Abstract][Full Text] [Related]
66. Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes.
Momin S; Flores S; Angel B B; Codner D E; Carrasco P E; Perez-Bravo F
Diabetes Res Clin Pract; 2009 Mar; 83(3):289-94. PubMed ID: 19147248
[TBL] [Abstract][Full Text] [Related]
67. Endocrine autoimmune disease: genetics become complex.
Wiebolt J; Koeleman BP; van Haeften TW
Eur J Clin Invest; 2010 Dec; 40(12):1144-55. PubMed ID: 20718847
[TBL] [Abstract][Full Text] [Related]
68. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex.
Viken MK; Blomhoff A; Olsson M; Akselsen HE; Pociot F; Nerup J; Kockum I; Cambon-Thomsen A; Thorsby E; Undlien DE; Lie BA
Genes Immun; 2009 Jun; 10(4):323-33. PubMed ID: 19295542
[TBL] [Abstract][Full Text] [Related]
69. Insulin-like growth factor 1 promoter polymorphism influences insulin gene variable number of tandem repeat-associated risk for juvenile onset type 1 diabetes.
Eerligh P; Roep BO; Giphart MJ; Koeleman BP
Tissue Antigens; 2004 Jun; 63(6):568-71. PubMed ID: 15140033
[TBL] [Abstract][Full Text] [Related]
70. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates.
Douroudis K; Laine AP; Heinonen M; Hermann R; Lipponen K; Veijola R; Simell O; Knip M; Uibo R; Ilonen J; Kisand K
Hum Immunol; 2009 Jul; 70(7):536-9. PubMed ID: 19376178
[TBL] [Abstract][Full Text] [Related]
71. A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease.
Awdeh ZL; Yunis EJ; Audeh MJ; Fici D; Pugliese A; Larsen CE; Alper CA
J Autoimmun; 2006 Nov; 27(3):174-81. PubMed ID: 17052889
[TBL] [Abstract][Full Text] [Related]
72. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
[TBL] [Abstract][Full Text] [Related]
73. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.
Vafiadis P; Bennett ST; Todd JA; Nadeau J; Grabs R; Goodyer CG; Wickramasinghe S; Colle E; Polychronakos C
Nat Genet; 1997 Mar; 15(3):289-92. PubMed ID: 9054944
[TBL] [Abstract][Full Text] [Related]
74. Molecular mechanisms of HLA association with autoimmune diseases.
Caillat-Zucman S
Tissue Antigens; 2009 Jan; 73(1):1-8. PubMed ID: 19017300
[TBL] [Abstract][Full Text] [Related]
75. Trinucleotide repeats of programmed cell death-1 gene are associated with susceptibility to type 1 diabetes mellitus.
Hiromine Y; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Asano K; Fukai A; Ogihara T
Metabolism; 2007 Jul; 56(7):905-9. PubMed ID: 17570250
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of IDDM8 susceptibility locus in a Russian simplex family data set.
Chistiakov DA; Seryogin YA; Turakulov RI; Savost'anov KV; Titovich EV; Zilberman LI; Kuraeva TL; Dedov II; Nosikov VV
J Autoimmun; 2005 May; 24(3):243-50. PubMed ID: 15848047
[TBL] [Abstract][Full Text] [Related]
77. Molecular aspects of HLA class II alphabeta heterodimers associated with IDDM susceptibility and protection.
Ettinger RA; Nepom GT
Rev Immunogenet; 2000; 2(1):88-94. PubMed ID: 11324697
[TBL] [Abstract][Full Text] [Related]
78. CTLA-4 promoter polymorphisms are associated with latent autoimmune diabetes in adults.
Douroudis K; Prans E; Uibo R
Hum Immunol; 2009 Nov; 70(11):921-4. PubMed ID: 19735686
[TBL] [Abstract][Full Text] [Related]
79. A combined genetics and genomics approach to unravelling molecular pathways in coeliac disease.
Wapenaar MC; Wijmenga C
Novartis Found Symp; 2005; 267():113-34; discussion 134-44. PubMed ID: 15999804
[TBL] [Abstract][Full Text] [Related]
80. Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population.
Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
BMC Med Genet; 2007 Aug; 8():54. PubMed ID: 17697317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
